362 related articles for article (PubMed ID: 10685879)
1. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter.
Woodward JJ; Compton DM; Balster RL; Martin BR
Eur J Pharmacol; 1995 Apr; 277(1):7-13. PubMed ID: 7635175
[TBL] [Abstract][Full Text] [Related]
3. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
[TBL] [Abstract][Full Text] [Related]
4. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
5. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells.
Nishimura M; Sato K; Okada T; Yoshiya I; Schloss P; Shimada S; Tohyama M
Anesthesiology; 1998 Mar; 88(3):768-74. PubMed ID: 9523822
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
7. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
8. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
9. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
10. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
[TBL] [Abstract][Full Text] [Related]
11. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
12. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
13. General anesthetic actions on norepinephrine, dopamine, and gamma-aminobutyric acid transporters in stably transfected cells.
Shahani SK; Lingamaneni R; Hemmings HC
Anesth Analg; 2002 Oct; 95(4):893-9, table of contents. PubMed ID: 12351264
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.
Apparsundaram S; Moore KR; Malone MD; Hartzell HC; Blakely RD
J Neurosci; 1997 Apr; 17(8):2691-702. PubMed ID: 9092590
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
19. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
Bryan-Lluka LJ; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
[TBL] [Abstract][Full Text] [Related]
20. Studies of selected phenyltropanes at monoamine transporters.
Kuhar MJ; McGirr KM; Hunter RG; Lambert PD; Garrett BE; Carroll FI
Drug Alcohol Depend; 1999 Aug; 56(1):9-15. PubMed ID: 10462087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
